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Opportunities and Challenges for Specialty 
Crops: Will They Sell If Developed?
Q&A
Moderator: Dan Lineberger
Texas A&M University
College Station, Texas 
Andrea Fonseca (Texas A&M University, College Station): You said that multinationals 
won’t work. Can you elaborate on that?
Roger Beachy: My point is that the multinational companies, who are the most success-
ful in the  science and technology and in product development in GM agriculture, are 
heavily criticized for the appearance that they are “taking over the world’s germplasm and 
will control farmers.” So, while what the report about the safety of GM foods has been 
scientifically validated, the multinationals are tainted in the eyes of some consumers. My 
colleague at Washington University, Professor Garland Allen, a historian of science said, 
“Roger I have a plan to make food available for free for everybody in the world.” While 
some may feel that government should take on this role, others of us believe that the 
private sector plays an important role in food and agriculture. 
Fonseca: Okay, I see what you mean.
Beachy: And he’s not alone. That was my context.
Fonseca: You mentioned EPA barriers. What, in your opinion, is the most significant 
barrier at the EPA?
Beachy: The interpretation of definitions. For example, virus resistance was referred to 
as a pesticide because it controls a pest. In contrast, conventional disease-resistant traits 
are not called pesticidal. Describing a transgenic trait as such implies that DNA, or in 
some case RNA, is being classified as a pesticide. Another one that concerns me is that 
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genes used to affect climate resilience—drought tolerance and so forth—are classified 
broadly by one agency as growth regulators. The definition of a growth regulator in that 
context seems ridiculous. A learning should go on and the learning is called biology. It’s 
called genetics. It’s called plant physiology. It’s called pathology. It’s called information 
that we appreciate as science, and the consensus that results is what we know as scientific 
validation. Those are some of my concerns about the EPA. The need for regulation of 
GM crops of this type is something that I don’t understand. 
Nikhil Patil (Texas A&M AgrLife Research, College Station): You did a great job in 
presenting the whole perspective on local food security. We all know that we cannot 
achieve global food security without GMOs. In the early years, Europeans failed, in my 
opinion, to provide good education about GMOs. In the United States we are doing a 
little bit better in terms of educating people. Do you think we can improve global food 
security by inclusion of GMOs?
Beachy: We have a long way to go. We have yet to see Golden Rice in the market; it has 
been delayed for nearly 5 years. GM technologies are not yet considered part of the nu-
trition solution. We haven’t yet seen Bt brinjal5 in the Philippines, Bangladesh, or India. 
In the early days, China released some GM peppers, cucumbers and tomatoes that were 
virus resistant. So we know it is possible to move products of public sector research to the 
marketplace. There are ongoing field trials in Uganda with a bacterium-resistant banana, 
and I think that there are disease-resistant banana, cassava and sweet potato in trials. And 
there is GM cowpea with resistance to bruchid beetles. It may well be that the advantage for 
use of GM-horticulture crops will occur more effectively in less economically advantaged 
countries than in ours. It doesn’t sound very good for a specialty crops meeting like this 
one, but that may well be the way it will happen. Perhaps we need to think in terms of 
importing sweet-potato fries from Uganda made from GM plants. 
Bob Avant (Texas A&M AgriLife Research, College Station): Recently USDA announced 
they were going to go through an EIS6 process for deregulation of GMOs using the NIFA7 
process. Typically, environmental activists use that as a way to delay or kill projects. Do 
you think that doing EISs on GMOs will have a chilling effect on getting additional 
traits deregulated?
Beachy: I don’t think it will if we do it right. We ought to take our medicine if that’s the 
way it’s going to go before the law is changed, if ever; perhaps we could include EIS-
related studies with every field trial. Create the portfolio and just get it done. Of course, 
this requires that the EPA and USDA define adequately what an acceptable EIS is. We 
should learn the steps and collect the necessary data up front. That way, it won’t cost the 
developer additional years and another few million dollars. Just do it.
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Bill McCutchen (Texas A&M AgriLife Research, College Station): You’ve been through 
the genesis of this. What do you see as the path of least resistance for public institu-
tions—land-grant universities—to actually get our transgenic specialty crops deregulated? 
You pointed out some facts, but why can’t we come together and get it done?
Beachy: I don’t know. Why can’t you?
McCutchen: I don’t know. That’s why you’re the keynote speaker.
Beachy: Something occurred recently that shocked me. At an annual meeting of the 
American Phytopathological Society, I gave a forward-looking speech and a number of 
students who gathered around afterward said they had been told by their professors not 
to consider GM approaches. We have to start in our universities by saying that GM tech-
nologies are part of plant breeding. Everybody in science should know about genetics and 
plant breeding, including genetic engineering, and their role in agriculture sustainability, 
food safety, nutrition, and so on. We’ve got to start with education. The other approach 
may well be to begin talking about our current crop-genetic-engineering research proj-
ects in a transparent way, so that when the results are in we can say, “This is what your 
investment has brought us.” In the world of cancer research, they talk about solutions for 
many years before they accomplish them, which in a way justifies the continuing invest-
ments in cancer research, and why there is a cancer center at a hospital or in a university 
setting near you. In agriculture we are reluctant to describe our goals or that we might 
be using advanced genetics to achieve them. Perhaps there’s a marketing point here that 
universities should pursue. Maybe it should be led by the APLU8. Maybe it should be 
led by science societies, by the groups of plant producers or plant breeders who come 
forward to say that this is a key part of the technology that will achieve drought tolerance 
or insect resistance or lower-glycemic-index rice that tastes like its high-glycemic-index 
counterpart. Whatever the goal, we should indicate it now and that we expect achieve-
ment in 5 to 0 years. Maybe we should be more aggressive in our research reports and 
describe what we in agriculture are working toward.  We have a scientific capacity here 
that is compelling and we have too long been in the closet on so many of these important 
issues. Sometimes we are our own worst enemies; for the first 5 years of crop genetic 
engineering, many public plant breeders were saying that GM would not be a useful to 
agriculture. We have a lot to do in our own universities. At most university campuses on 
which I speak, there are  students of agriculture, among others, who have reached the 
conclusion that GM crops and foods are not good for the environment and not good 
for health. They have either not been taught the facts, or the available information has 
not been taught correctly. If we can’t get it right in our own schools of agriculture, how 
can we expect the mom with three kids to think that GM foods are okay? This is not 
something that I thought about just last night, but something that has been happening 
for a number of years. It will be interesting to see if Dennis Gonsalves9 feels the same way. 
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We have really failed in our schools of agriculture and colleges of arts. People at the little 
college I went to in Indiana thought that Vandana Shiva walks on water. When I gave 
a lecture there, some were sure that I was a devil from Monsanto. It’s an amazing thing. 
Anti-science people, or at least those who are anti-modern agriculture, are from a small 
percentage of the population who demand policies based upon their voices. Perhaps we 
in the field did not do our jobs in the early years; so what should we do now, 0 years 
later? I’m not sure, and that’s why I ask rhetorically, “Why can’t you get it done?” I don’t 
know if we have yet formulated a good suggestion of what to do to counter the mistruths 
that are being promulgated about GM foods. 
Chris Dzuik (H-E-B, San Antonio): I work for a retailer and we try to be transparent 
with our customers. With the pink-slime issue, the social media took over and a product 
that was acceptable is now gone. With new technologies such as irradiation, we can refute 
what some of the activist groups are saying through research. How can I, as an employee 
of this company, contradict what we see on social media, such as posters saying that GM 
creates autistic children, allergens, and so on. Where would I go to find good data?
Beachy: I don’t think it’s at a single location or website; nor is the information being 
used in way that is reaching those who want useful information. Of the population who 
are against GM foods, I would venture to guess that many are also against childhood 
 vaccines. An article by Marcel Kuntz in the October 0 issue of EMBO Reports, asked 
the question, “In the postmodern assault on science: If all truths are equal, who cares 
what science has to say?” If religious truth or philosophical truth or the truth from a blog 
is equal to the truth of science, and policymakers consider them to be equivalent, then 
how do we expect to move forward? I suspect that many who are attending this meeting 
can agree that we have a science-literacy problem;  we as scientists also have a believability 
problem, and for some there is a trust problem.
Bolormaa Jamiyansuren (University of Minnesota, Minneapolis): I do research on inter-
national trade of GMO products. How do you see the future for North American GMO 
producers, especially given that the competition is unfair. For example, the European 
Union had a strict labeling law that provided ample time for them to catch up with 
American producers, and now the law isn’t so strictly enforced.
Beachy: I don’t have a clear answer or a prediction about trade of GMO products. I 
happen to know a little bit about the China situation. A year or so ago, China said that 
they would not allow the growing of GM soybeans or corn, which some interpreted as 
a delaying tactic so that China could build its local industry before permitting cropping 
using foreign seeds. Meanwhile there has been a great deal of investment in agriculture and 
food-related science and biotechnology, and seed companies in China will soon market 
their own advanced seed varieties, and multinational seed companies may then be allowed 
to compete. With the use of non-tariff trade barriers such as this, I don’t know if we can 
expect any legislative or judicial body to exact changes. And, Europe probably will go at its 
